Citation 130456

LANDOLT,JL: AHAMMADSAHIB,KI: HOLLINGWORTH,RM: BARR,R: CRANE,FL: BUERCK,NL: MC CABE,GP: MC LAUGHLIN,JL:. (1995). DETERMINATION OF STRUCTURE-ACTIVITY RELATIONSHIPS OF ANNONACEOUS ACETOGENINS BY INHIBITION OF OXYGEN UPTAKE IN RAT LIVER MITOCHONDRIA.. 98(1)

Citation Details

TitleDETERMINATION OF STRUCTURE-ACTIVITY RELATIONSHIPS OF ANNONACEOUS ACETOGENINS BY INHIBITION OF OXYGEN UPTAKE IN RAT LIVER MITOCHONDRIA.
AuthorsLANDOLT,JL: AHAMMADSAHIB,KI: HOLLINGWORTH,RM: BARR,R: CRANE,FL: BUERCK,NL: MC CABE,GP: MC LAUGHLIN,JL:
Year1995
Volume98
Issue1

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
STRONG ACTIVITY
2
CROWN GALL TUMOR INHIBITION
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROLLINIASTATIN 2
ACTIVE
3
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROLLINIASTATIN 2
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
STRONG ACTIVITY
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
WEAK ACTIVITY
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ROLLINIASTATIN 2
STRONG ACTIVITY
7
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACIN,4-DEOXY:
STRONG ACTIVITY
8
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATACIN,4-DEOXY:
WEAK ACTIVITY
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACIN,4-DEOXY:
STRONG ACTIVITY
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACIN,4-DEOXY:
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACIN,4-DEOXY:
STRONG ACTIVITY
12
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATIN
WEAK ACTIVITY
13
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLANIN
ACTIVE
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE
STRONG ACTIVITY
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE
STRONG ACTIVITY
16
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE
STRONG ACTIVITY
17
CROWN GALL TUMOR INHIBITION
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATACINONE
ACTIVE
18
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATACINONE
ACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,30-HYDROXY:
STRONG ACTIVITY
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,30-HYDROXY:
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,30-HYDROXY:
STRONG ACTIVITY
22
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,30-HYDROXY:
STRONG ACTIVITY
23
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATACINONE,30-HYDROXY:
ACTIVE
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,31-HYDROXY:
STRONG ACTIVITY
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,31-HYDROXY:
STRONG ACTIVITY
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,31-HYDROXY:
STRONG ACTIVITY
27
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BULLATACINONE,31-HYDROXY:
ACTIVE
28
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BULLATACINONE,31-HYDROXY:
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN
STRONG ACTIVITY
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN
STRONG ACTIVITY
31
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN
STRONG ACTIVITY
32
CROWN GALL TUMOR INHIBITION
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMICIN
ACTIVE
33
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMICIN
ACTIVE
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN,4-DEOXY:
STRONG ACTIVITY
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN,4-DEOXY:
STRONG ACTIVITY
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN,4-DEOXY:
ACTIVE
37
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICIN,4-DEOXY:
ACTIVE
38
CROWN GALL TUMOR INHIBITION
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMICIN,4-DEOXY:
ACTIVE
39
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMICIN,4-DEOXY:
WEAK ACTIVITY
40
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TRILOBACIN
STRONG ACTIVITY
41
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TRILOBACIN
ACTIVE
42
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TRILOBACIN
STRONG ACTIVITY
43
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TRILOBACIN
STRONG ACTIVITY
44
CROWN GALL TUMOR INHIBITION
PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
TRILOBACIN
ACTIVE
45
OXYGEN CONSUMPTION DECREASE
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
TRILOBACIN
ACTIVE
Show SPARQL Queries (1)